AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
DNA VACCINES WITH SINGLE-CHAIN FV FUSED TO FRAGMENT-C OF TETANUS TOXIN INDUCE PROTECTIVE IMMUNITY AGAINST LYMPHOMA AND MYELOMA
Authors: KING CA SPELLERBERG MB ZHU DL RICE J SAHOTA SS THOMPSETT AR HAMBLIN TJ RADL J STEVENSON FK
Citation: Ca. King et al., DNA VACCINES WITH SINGLE-CHAIN FV FUSED TO FRAGMENT-C OF TETANUS TOXIN INDUCE PROTECTIVE IMMUNITY AGAINST LYMPHOMA AND MYELOMA, Nature medicine, 4(11), 1998, pp. 1281-1286
FLUDARABINE AND HEMOLYTIC-ANEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: HAMBLIN TJ ORCHARD J MYINT H OSCIER DG
Citation: Tj. Hamblin et al., FLUDARABINE AND HEMOLYTIC-ANEMIA IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(9), 1998, pp. 3209-3210
CLINICAL AND LABORATORY STUDIES
Authors: BENNETT JM HAMBLIN TJ
Citation: Jm. Bennett et Tj. Hamblin, CLINICAL AND LABORATORY STUDIES, Leukemia research, 22(10), 1998, pp. 5-6
PYODERMA-GANGRENOSUM
Authors: HAMBLIN TJ
Citation: Tj. Hamblin, PYODERMA-GANGRENOSUM, Lancet, 351(9109), 1998, pp. 1134-1134
IN PATIENTS WITH LYMPHOID TUMORS RECOVERING FROM THE AUTOIMMUNE COMPLICATIONS OF FLUDARABINE, RELAPSE MAY BE TRIGGERED BY CONVENTIONAL CHEMOTHERAPY
Authors: ORCHARD J BOLAM S MYINT H OSCIER DG HAMBLIN TJ
Citation: J. Orchard et al., IN PATIENTS WITH LYMPHOID TUMORS RECOVERING FROM THE AUTOIMMUNE COMPLICATIONS OF FLUDARABINE, RELAPSE MAY BE TRIGGERED BY CONVENTIONAL CHEMOTHERAPY, British Journal of Haematology, 102(4), 1998, pp. 1112-1113
CLINICIAN OVERVIEW OF PLATELET SUPPORT
Authors: HAMBLIN TJ
Citation: Tj. Hamblin, CLINICIAN OVERVIEW OF PLATELET SUPPORT, Transfusion science, 18(3), 1997, pp. 351-353
DNA VACCINATION AS CANCER-IMMUNOTHERAPY
Authors: ZHU D SPELLERBERG MB THOMPSETT A KING CA HAMBLIN TJ STEVENSON FK
Citation: D. Zhu et al., DNA VACCINATION AS CANCER-IMMUNOTHERAPY, Biochemical Society transactions, 25(2), 1997, pp. 743-747
CHRONIC LYMPHOCYTIC-LEUKEMIA - THE NATURE OF THE LEUKEMIC-CELL
Authors: HAMBLIN TJ OSCIER DG
Citation: Tj. Hamblin et Dg. Oscier, CHRONIC LYMPHOCYTIC-LEUKEMIA - THE NATURE OF THE LEUKEMIC-CELL, Blood reviews, 11(3), 1997, pp. 119-128
EARLY TRANSFORMATION TO ACUTE MYELOBLASTIC-LEUKEMIA WITH THE ACQUISITION OF INV(16) IN PH POSITIVE CHRONIC GRANULOCYTIC-LEUKEMIA
Authors: MYINT H ROSS FM HALL JL HAMBLIN TJ
Citation: H. Myint et al., EARLY TRANSFORMATION TO ACUTE MYELOBLASTIC-LEUKEMIA WITH THE ACQUISITION OF INV(16) IN PH POSITIVE CHRONIC GRANULOCYTIC-LEUKEMIA, Leukemia research, 21(5), 1997, pp. 473-474
A PATIENT WITH MYELOMA WHO STILL HAS PURE RED-CELL APLASIA DESPITE THE MOST INTENSIVE IMMUNE MODULATION
Authors: ORCHARD J MYINT H HAMBLIN TJ
Citation: J. Orchard et al., A PATIENT WITH MYELOMA WHO STILL HAS PURE RED-CELL APLASIA DESPITE THE MOST INTENSIVE IMMUNE MODULATION, Leukemia research, 21(4), 1997, pp. 353-354
TRISOMY-12 IN CLL REVISITED
Authors: HAMBLIN TJ
Citation: Tj. Hamblin, TRISOMY-12 IN CLL REVISITED, Leukemia research, 21(11-12), 1997, pp. 1025-1026
DNA VACCINES AGAINST LYMPHOMA - PROMOTION OF ANTIIDIOTYPIC ANTIBODY-RESPONSES INDUCED BY SINGLE-CHAIN FV GENES BY FUSION TO TETANUS TOXIN FRAGMENT-C
Authors: SPELLERBERG MB ZHU D THOMPSETT A KING CA HAMBLIN TJ STEVENSON FK
Citation: Mb. Spellerberg et al., DNA VACCINES AGAINST LYMPHOMA - PROMOTION OF ANTIIDIOTYPIC ANTIBODY-RESPONSES INDUCED BY SINGLE-CHAIN FV GENES BY FUSION TO TETANUS TOXIN FRAGMENT-C, The Journal of immunology, 159(4), 1997, pp. 1885-1892
ATYPICAL LYMPHOCYTE MORPHOLOGY - AN ADVERSE PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN STAGE-A CLL INDEPENDENT OF TRISOMY-12
Authors: OSCIER DG MATUTES E COPPLESTONE A PICKERING RM CHAPMAN R GILLINGHAM R CATOVSKY D HAMBLIN TJ
Citation: Dg. Oscier et al., ATYPICAL LYMPHOCYTE MORPHOLOGY - AN ADVERSE PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN STAGE-A CLL INDEPENDENT OF TRISOMY-12, British Journal of Haematology, 98(4), 1997, pp. 934-939
MYELOMA V-L AND V-H GENE-SEQUENCES REVEAL A COMPLEMENTARY IMPRINT OF ANTIGEN SELECTION IN TUMOR-CELLS
Authors: SAHOTA SS LEO R HAMBLIN TJ STEVENSON FK
Citation: Ss. Sahota et al., MYELOMA V-L AND V-H GENE-SEQUENCES REVEAL A COMPLEMENTARY IMPRINT OF ANTIGEN SELECTION IN TUMOR-CELLS, Blood, 89(1), 1997, pp. 219-226
APPOINTMENT OF ASSISTANT EDITORS
Authors: BENNETT JM HAMBLIN TJ
Citation: Jm. Bennett et Tj. Hamblin, APPOINTMENT OF ASSISTANT EDITORS, Leukemia research, 20(9), 1996, pp. 703-703
RESPONSE OF B-CELL LYMPHOMA TO A COMBINATION OF BISPECIFIC ANTIBODIESAND SAPORIN
Authors: FRENCH RR BELL AJ HAMBLIN TJ TUTT AL GLENNIE MJ
Citation: Rr. French et al., RESPONSE OF B-CELL LYMPHOMA TO A COMBINATION OF BISPECIFIC ANTIBODIESAND SAPORIN, Leukemia research, 20(7), 1996, pp. 607-617
FROM DENDRITIC CELLS TO TUMOR VACCINES
Authors: HAMBLIN TJ
Citation: Tj. Hamblin, FROM DENDRITIC CELLS TO TUMOR VACCINES, Lancet, 347(9003), 1996, pp. 705-706
IMMUNOLOGICAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
Authors: HAMBLIN TJ
Citation: Tj. Hamblin, IMMUNOLOGICAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES, Seminars in hematology, 33(2), 1996, pp. 150-162
IMMUNOGLOBULIN GENE USAGE IN MALIGNANT-LYMPHOMAS
Authors: STEVENSON FK ZHU D CHAPMAN CJ THOMPSETT A WRIGHT DH PAWARDE J SAHOTA S OSCIER DG HAMBLIN TJ
Citation: Fk. Stevenson et al., IMMUNOGLOBULIN GENE USAGE IN MALIGNANT-LYMPHOMAS, Journal of pathology, 179, 1996, pp. 53-53
TRACKING OF THE V-4-34 (V(H)4-21) GENE IN HUMAN TONSIL REVEALS CLONALISOTYPE SWITCH EVENTS AND A HIGHLY VARIABLE DEGREE OF SOMATIC HYPERMUTATION
Authors: CHAPMAN CJ MOCKRIDGE CI HAMBLIN TJ STEVENSON FK
Citation: Cj. Chapman et al., TRACKING OF THE V-4-34 (V(H)4-21) GENE IN HUMAN TONSIL REVEALS CLONALISOTYPE SWITCH EVENTS AND A HIGHLY VARIABLE DEGREE OF SOMATIC HYPERMUTATION, Clinical and experimental immunology, 105(2), 1996, pp. 360-368
T(8-21) MYELODYSPLASIA
Authors: HAMBLIN TJ BENNETT JM
Citation: Tj. Hamblin et Jm. Bennett, T(8-21) MYELODYSPLASIA, British Journal of Haematology, 92(3), 1996, pp. 766-767
IG V-H GENE MUTATIONAL PATTERNS INDICATE DIFFERENT TUMOR-CELL STATUS IN HUMAN MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Authors: SAHOTA SS LEO R HAMBLIN TJ STEVENSON FK
Citation: Ss. Sahota et al., IG V-H GENE MUTATIONAL PATTERNS INDICATE DIFFERENT TUMOR-CELL STATUS IN HUMAN MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, Blood, 87(2), 1996, pp. 746-755
DIFFERENTIAL USAGE OF AN AUTOANTIBODY-ASSOCIATED V-H GENE, VH4-21, BYHUMAN B-CELL TUMORS
Authors: STEVENSON FK SPELLERBERG MB CHAPMAN CJ HAMBLIN TJ
Citation: Fk. Stevenson et al., DIFFERENTIAL USAGE OF AN AUTOANTIBODY-ASSOCIATED V-H GENE, VH4-21, BYHUMAN B-CELL TUMORS, Leukemia & lymphoma, 16(5-6), 1995, pp. 379-384
PLASMID VACCINATION FOR B-CELL LYMPHOMA
Authors: HAWKINS RE ASHWORTH LJ RUSSELL SJ HAMBLIN TJ ZHU DL WILSON C STEVENSON FK
Citation: Re. Hawkins et al., PLASMID VACCINATION FOR B-CELL LYMPHOMA, European journal of cancer, 31A, 1995, pp. 26-26
PATTERN OF USAGE OF THE V(H)4-21 GENE BY B-LYMPHOCYTES IN A PATIENT WITH EBV INFECTION INDICATES ONGOING MUTATION AND CLASS SWITCHING
Authors: CHAPMAN CJ SPELLERBERG MB HAMBLIN TJ STEVENSON FK
Citation: Cj. Chapman et al., PATTERN OF USAGE OF THE V(H)4-21 GENE BY B-LYMPHOCYTES IN A PATIENT WITH EBV INFECTION INDICATES ONGOING MUTATION AND CLASS SWITCHING, Molecular immunology, 32(5), 1995, pp. 347-353
Risultati: 1-25 | 26-50 | 51-54